FCM
IRWD icon

Farallon Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Farallon Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,000
Closed -$45.6K – 139
2026
Q1 		$45.6K Hold
13,000
– – ﹤0.01% 169
2025
Q4 		$43.8K Hold
13,000
– – ﹤0.01% 151
2025
Q3 		$17K Hold
13,000
– – ﹤0.01% 144
2025
Q2 		$9.32K Hold
13,000
– – ﹤0.01% 145
2025
Q1 		$19.1K Hold
13,000
– – ﹤0.01% 144
2024
Q4 		$57.6K Hold
13,000
– – ﹤0.01% 146
2024
Q3 		$53.6K Hold
13,000
– – ﹤0.01% 154
2024
Q2 		$84.8K Hold
13,000
– – ﹤0.01% 150
2024
Q1 		$113K Buy
+13,000
New +$158K ﹤0.01% 157

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Farallon Capital Management's IRWD Position: Q2 2026 in Review

Farallon Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 13,000 shares — an estimated $45.6K sold.

Farallon Capital Management first reported a position in IRWD in Q1 2024 and held it in 9 quarters. The position peaked at $113K in Q1 2024. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Farallon Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Farallon Capital Management sold 13,000 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $45.6K.
  • Farallon Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2024 and held it in 9 quarters.
  • Farallon Capital Management's Ironwood Pharmaceuticals position peaked at $113K in Q1 2024.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.